Indicators

Markets:

News

Latest News about BIIB

Recent news which mentions BIIB

< Previous 1 2 3 4 5 6 7 8 9

...

Biogen Beats Q1 Earnings Expectations As Two Newcomer Drug Sales Spike, Avoids Tariff Impact

May 01, 2025

10 Worst Performing Large-Caps Last 12 Months

May 01, 2025

Earnings Scheduled For May 1, 2025

May 01, 2025

14 Analysts Have This To Say About Biogen

April 22, 2025

Trump's New Order Targets Drug Pricing Transparency And Medicare Cost Reduction

April 16, 2025

Europe Approves Eisai-Biogen's Alzheimer's Drug 'Under Strict Conditions' After Initial Negative Opinion

April 16, 2025

Vertex, Alnylam Best Positioned As Biopharma Braces For Tariff Impact, Goldman Sachs Flags Regeneron, Biogen Risks

April 04, 2025

What 14 Analyst Ratings Have To Say About Biogen

April 04, 2025

European Drug Regulator Gives Thumbs Down To Eli Lilly's Alzheimer's Drug, Analyst Says It Is Incremental Win For Biogen

March 28, 2025

Beyond GLP-1 Drugs: This Opportunity at Eli Lilly Could Surprise Everyone in 2025

March 27, 2025

Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed

March 21, 2025

Novartis New Data From Single-Dose Gene Therapy Shows Meaningful Efficacy, Safety In Patients With Spinal Muscular Atrophy

March 19, 2025

How Is The Market Feeling About Biogen?

March 07, 2025

Alzheimer's Drugs From Eli Lilly And Biogen Still Deemed Too Costly For NHS Funding

March 06, 2025

NHS England's Transition From Biogen's Drug To Sandoz's Biosimilar Sparks Alarm As Multiple Sclerosis Patients Report Severe Effects

February 24, 2025

Biogen Strengthens Pipeline With Stoke Therapeutic's Dravet Syndrome Candidate Via Multi-Million Dollar Deal

February 18, 2025

Leqembi And Skyclarys Expected To Drive Biogen's Future Growth: Analysts

February 13, 2025

Biogen Analysts Lower Their Forecasts After Q4 Results

February 13, 2025

Forecasting The Future: 10 Analyst Projections For Biogen

February 13, 2025

Biogen Delivers Q4 Beat, Analyst Focuses On Leqembi Expansion, 2025 Outlook

February 12, 2025

Biogen (BIIB) Q4 2024 Earnings Call Transcript

February 12, 2025

Stocks Trim Losses After Hot Inflation, Bonds Remain Pressured, Tesla Rebounds: What's Driving Markets Wednesday?

February 12, 2025

Biogen Q4 Earnings: Revenue And EPS Beat, Warns Lower 2025 Revenue, Inks R&D Funding Pact With Royalty Pharma

February 12, 2025

US Stocks Set For A Cautious Start Ahead Of Inflation Data: Expert Says 'Strong Bull Markets Tend To Roar Back To Life After Corrections'

February 12, 2025

Earnings Scheduled For February 12, 2025

February 12, 2025

Biogen Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

February 12, 2025

What To Expect From Alzheimer's Drugmaker Biogen's Q4 Earnings On Wednesday?

February 11, 2025

Deal Dispatch: Sage And Silvus Are Up For Sale, MrBeast Secures $20B For TikTok

January 31, 2025

Breaking Down Biogen: 18 Analysts Share Their Views

January 28, 2025

Deal Dispatch: Biden Punts TikTok Ban To Trump, Plus Another Legacy Retailer Goes Bankrupt

January 17, 2025

< Previous 1 2 3 4 5 6 7 8 9

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.